CoChat

Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Carcinoid syndrome represents the most common functional syndrome that affects patients with neuroendocrine neoplasms. Its clinical presentation is really heterogeneous, ranging from mild and often misdiagnosed symptoms to severe manifestations, that significantly worsen the patient's quality of life, such as difficult-to-control diarrhoea and fibrotic complications. Serotonin pathway alteration plays a central role in the pathophysiology of carcinoid syndrome, accounting for most clinical manifestations and providing diagnostic tools. Serotonin pathway is complex, resulting in production of biologically active molecules such as serotonin and melatonin, as well as of different intermediate molecules and final metabolites. These activities require site- and tissue-specific catalytic enzymes. Variable expression and activities of these enzymes result in different clinical pictures, according to primary site of origin of the tumour. At the same time, the biochemical diagnosis of carcinoid syndrome could be difficult even in case of typical symptoms. Therefore, the accuracy of the diagnostic methods of assessment should be improved, also attenuating the impact of confounding factors and maybe considering new serotonin precursors or metabolites as diagnostic markers. Finally, the prognostic role of serotonin markers has been only evaluated for its metabolite 5-hydroxyindole acetic acid but, due to heterogeneous and biased study designs, no definitive conclusions have been achieved…

Overview

Integrity signals

Registry

Crossref · 10.1007/s11154-020-09547-8

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 90 · Cited by 47

Research works printed but not linked: 1

  1. Pandit S, Bhusal K. Carcinoid syndrome. Treasure Island: StatPearls; 2019.

Metadata

Authors
on behalf of, N. I. K. E., Fanciulli, G., Ruggeri, R. M., Grossrubatscher, E., Calzo, F. L., Wood, T. D., Faggiano, A., Isidori, A., & Colao, A.
Affiliations
  • University of Sassari (IT)
  • University of Messina (IT)
  • Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
  • Federico II University Hospital (IT)
  • University at Buffalo, State University of New York (US)
  • Sapienza University of Rome (IT)
Corresponding author
Faggiano, Antongiulio
Venue
Reviews in Endocrine and Metabolic Disorders
Published
2020-03-10
Volume
21
Issue
4
Pages
599-612
ISSN
  • 1389-9155 (ISSN-L)
  • 1573-2606
OpenAlex
W3011793537
Cited by
47
References
90
Citations by year
2026: 1 · 2025: 13 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 8 · 2020: 2
FWCI
0.98
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Reviews in Endocrine and Metabolic Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
Keywords
carcinoid syndrome, serotonin pathway, neuroendocrine neoplasms, melatonin, serotonin metabolites, 5-hydroxyindoleacetic acid, tryptophan hydroxylase, diarrhea, diagnostic biomarkers, prognosis, pathogenesis
MeSH terms
Humans, Malignant Carcinoid Syndrome, Phenylalanine, Pyrimidines, Serotonin, Tryptophan Hydroxylase, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. https://app.cochat.ai/papers/10.1007/s11154-020-09547-8
The paper
on behalf of, N. I. K. E., Fanciulli, G., Ruggeri, R. M., Grossrubatscher, E., Calzo, F. L., Wood, T. D., Faggiano, A., Isidori, A., & Colao, A. (2020). Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-020-09547-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.